In an interventional study, the use of insulin in T2DM patients who lack glycemic control and were originally on oral hypoglycemic drugs was associated with a reduction of HbA1c concomitant with an increase in serum leptin [41]. The gene discussed is INS; the disease is type 2 diabetes mellitus.